Technical method for inhibiting scar hyperplasia by adopting alternating square wave electric field

Through the application of alternating square wave electric field, the pain and recurrence problems of scar treatment in the prior art are solved, and the non-invasive and efficient scar inhibition effect is achieved, and the formation and hyperplasia of scars are reduced.

CN118925059APending Publication Date: 2024-11-12THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411143544.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is difficult to effectively prevent and treat scar formation. Traditional methods have problems of pain and recurrence, and it is difficult to completely eradicate the scars that have been formed.

Method used

The alternating square wave electric field treatment method is used. The electric field waveform is square wave, the electric field intensity is between 50mv/mm and 200mv/mm, and the electric field period is between 1 min and 60 min. The transformation of fibroblasts is inhibited by the alternating square wave electric field and Excessive deposition of extracellular matrix.

Benefits of technology

Effectively alleviate scar formation, provide a non-invasive and efficient treatment method, inhibits the transformation of myofibroblasts and the deposition of collagen, and reduces the thickness, hardness and hyperplasia index of scars.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118925059A_ABST
    Figure CN118925059A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of bioelectricity treatment, and discloses a technical method for inhibiting scar hyperplasia by adopting an alternating square wave electric field, the electric field waveform of the alternating square wave electric field is a square wave, the electric field intensity is 50mv / mm-200mv / mm, and the electric field period is 1min-60min. Through verification, it is found that the alternating square wave electric field can inhibit fibroblasts from being converted into myofibroblasts, meanwhile, excessive deposition of extracellular matrixes can be inhibited, and scar formation can be effectively relieved; the technology provided by the invention provides a brand new thought for non-invasive and efficient treatment of scars.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioelectric treatment and relates to a technical method for inhibiting scar hyperplasia by using an alternating square wave electric field. Background Art

[0002] Scar is a general term for the appearance and histopathological changes of normal skin tissue caused by various traumas. It is an inevitable product of the human body's trauma repair process. When scar growth exceeds a certain limit, various complications will occur, such as destruction of appearance and functional activity disorders, which will cause great physical and mental pain to patients, especially scars left over from burns, scalds, and severe trauma. The treatment of scars is very tricky and it is difficult to obtain very satisfactory results. Theoretically, once a scar is formed, even with the most sophisticated surgical methods, it can be partially improved, but it cannot be completely eradicated. Therefore, taking various measures to prevent scar formation to the greatest extent is equally important as the treatment of scars.

[0003] Pathological scars include hypertrophic scars and keloids, and their common histological characteristics are excessive proliferation of fibroblasts and excessive deposition of extracellular matrix. Existing clinical intervention methods include surgical resection, injection of glucocorticoids, and laser treatment, but there are problems such as pain and easy recurrence, so it is urgent to develop new non-invasive scar treatment technologies. At present, bioelectric fields play an important role in embryonic development, regeneration, tumor and wound healing, and are gradually applied in clinical practice. Domestic and foreign studies have also found that degenerate waves (DW) can maximally downregulate the expression of type I collagen in keloid fibroblasts, and the establishment of an oscillating electric field treatment model for spinal cord injury can inhibit scar formation. Summary of the invention

[0004] In view of this, the purpose of the present invention is to develop a new non-invasive and efficient scar treatment technology.

[0005] In order to achieve the above object, the present invention provides the following technical solutions:

[0006] A technical method for inhibiting scar hyperplasia by using an alternating square wave electric field, the method is as follows: using an alternating square wave electric field to treat scars, wherein the electric field waveform of the alternating square wave electric field is a square wave, the electric field strength is 50mv / mm-200mv / mm, and the electric field period is 1min-60min.

[0007] Further, the electric field waveform of the alternating square wave electric field is a square wave, and the combination of electric field strength and electric field period includes: or the electric field strength is 50mv / mm, and the electric field period is 30min; or the electric field strength is 100mv / mm, and the electric field period is 30min; or the electric field strength is 150mv / mm, and the electric field period is 30min; or the electric field strength is 200mv / mm, and the electric field period is 30min; or the electric field strength is 50mv / mm, and the electric field period is 10min; or the electric field strength is 100mv / mm, and the electric field period is 10min; or the electric field strength is 150mv / mm, and the electric field period is 10min; or the electric field strength is 200mv / mm, and the electric field period is 10min.

[0008] In order to achieve the above-mentioned object, the present invention also provides a product for treating scars, which is a therapeutic device that uses square waves to mainly treat or assist in treating scars.

[0009] Furthermore, the therapeutic device is a portable electric field therapeutic device or an alternating current therapeutic device.

[0010] Furthermore, the conductive electrode sheet of the therapeutic device is attached 0.5 cm outside the scar.

[0011] Furthermore, the electric field strength was 150 mv / mm and the power was applied continuously for 6 h every day.

[0012] Furthermore, the product is an in vitro electrification model product, in which an alternating electric field power supply is applied to a standard silver / silver chloride electrode, and a small chamber electrification model is formed through ST electrolyte, agar salt bridge, and culture medium.

[0013] The beneficial effects of the present invention are as follows: the present invention has verified that the alternating square wave electric field can inhibit the transformation of fibroblasts into myofibroblasts, and at the same time can inhibit the excessive deposition of extracellular matrix, and can effectively reduce the formation of scars; the technology of the present invention provides a new idea for the non-invasive and efficient treatment of scars. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] In order to make the purpose, technical solutions and advantages of the present invention more clear, the present invention will be described in detail below in conjunction with the accompanying drawings, wherein:

[0015] Figure 1 In the embodiments of the present invention: Figure A is the WB result of the alternating square wave electric field inhibiting TGF-β-induced myofibroblast transformation and collagen deposition; Figure B is the statistical result of Figure A, n=3, * represents P<0.05, and the data are expressed as mean ± standard error (SEM); Figures C and D are the immunofluorescence results of the alternating square wave electric field inhibiting TGF-β-induced α-SMA and Col-1 expression;

[0016] Figure 2In the embodiments of the present invention: Figure A is a rabbit ear scar model and a power-on flow chart; Figure B is a real picture of the rabbit ear scar being powered on; Figure C is a wound surface or scar picture of the scar group (Con) and the alternating square wave electric field treatment group (SWEFs) on day 0, day 28, and day 49; Figure D is a statistical chart of scar thickness, scar hardness, and scar elevation index (SEI) of normal skin (Normal skin), scar model group (Untreated HS), and alternating square wave electric field treatment group (SWEFs treated HS) on day 49; Figures E, F, and G are the results of hematoxylin-eosin staining (HE), Masson staining (Massion), and Sudan red staining (Sirius red) of (Normal skin), scar model group (Untreated HS), and alternating square wave electric field treatment group (SWEFs treated HS) on day 49;

[0017] Figure 3 In the embodiment of the present invention: Figure A is an alternating square wave waveform diagram; Figure B is a schematic diagram of external power-on and a device connection diagram; Figure C is a diagram of internal power-on and a device connection diagram;

[0018] Figure 4 Graphs showing experimental results of some combinations of electric field intensity and electric field period according to an embodiment of the present invention;

[0019] Figure 5 In the embodiments of the present invention: Figure A is a heat map of gene expression differences among the control group, TGF-β and TGF-β+SWEFs; Figure B is a volcano map of up-regulated and down-regulated differentially expressed genes among the two groups of TGF-β and TGF-β+SWEFs; Figure C is a GO enrichment analysis map of differentially expressed genes among the two groups of TGF-β and TGF-β+SWEFs; Figure D is a KEGG enrichment analysis map of differentially expressed genes among the two groups of TGF-β and TGF-β+SWEFs; Figure E is a visualized heat map analysis of TGF-β pathway-related genes among the three groups of con, TGF-β and TGF-β+SWEFs. DETAILED DESCRIPTION

[0020] The following describes the embodiments of the present invention by specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that the illustrations provided in the following embodiments only illustrate the basic concept of the present invention in a schematic manner, and the following embodiments and features in the embodiments can be combined with each other without conflict.

[0021] Example:

[0022] This embodiment has found through experiments that the alternating square wave electric field has the effect of inhibiting scarring when the electric field strength is between 50mv / mm and 200mv / mm (including 50mv / mm and 200mv / mm) and the electric field period is between 1min and 60min (including 1min and 60min). In particular, the effect of inhibiting scarring in in vitro and in vivo experiments was implemented when the electric field strength was 150mv / mm and the electric field period was 30min.

[0023] The inventors cultured primary fibroblasts in vitro and constructed a myofibroblast model by inducing TGF-β. This cell model can induce collagen secretion, increased deposition, and transformation of fibroblasts into myofibroblasts. It is currently one of the commonly used models for in vitro fibrosis research. Figure 3 B. The inventors established an in vitro fibroblast electrification model through previous research. An alternating electric field power supply was applied to a standard silver / silver chloride electrode, and a small chamber electrification model was formed through ST electrolyte, agar salt bridge, and culture medium. Figure 3 A is a square wave waveform. Western Blot experiments were performed after extracting fibroblast proteins from the control group, TGF-β induced group, and TGF-β induced + alternating electric field treatment group (TGF-β+SWEFs).

[0024] See attached Figure 1 A and attached Figure 1 B. It was found that TGF-β can significantly enhance the expression of extracellular matrix such as fibronectin (FN), collagen 1 (Col-1) and collagen 3 (Col-3) as well as myofibroblast marker (α-SMA), indicating that TGF-β can induce myofibroblast transformation and collagen deposition, while the square wave electric field with an electric field strength of 150mv / mm and an electric field period of 30min can inhibit TGF-β-induced myofibroblast transformation and collagen deposition, resulting in a decrease in FN expression by 58.6%, Col-1 expression by 62.0%, Col-3 expression by 73.5%, and α-SMA expression by 63.8%.

[0025] Next, the inventors confirmed by immunofluorescence staining that TGF-β can significantly enhance the fluorescence intensity of collagen 1 (Col-1) and myofibroblast marker (α-SMA), see Appendix Figure 1 C and attached Figure 1 D, it can be seen that the square wave electric field can reduce the high fluorescence intensity of Col-1 and α-SMA induced by TGF-β. In summary, the in vitro experiment of this example proves that the square wave electric field can inhibit the myofibroblast transformation and collagen deposition induced by TGF-β.

[0026] Next, the inventors conducted in vivo experiments.

[0027] The inventors constructed a rabbit ear scar model according to the rabbit ear scar model construction method reported in the literature. A 1cm*1cm full-thickness square wound was constructed on the rabbit ear abdomen and the perichondrium was removed. It was observed that the wound closed on the 28th day, and then the scar continued to proliferate and reached a peak on the 49th day. In order to further verify the effect of the alternating square wave electric field on the rabbit ear scar, a 21-day in vitro power-on experiment was conducted on the 28th day after the rabbit ear was wounded. See attached Figure 2 A. Attachment Figure 2 B and attached Figure 3 C; The specific method of in vivo electrification is as follows: a conductive electrode is attached 0.5 cm outside the rabbit ear scar, and a voltage regulator and a power generator are connected in sequence. The voltage is adjusted so that the voltage is maintained at about 3V to ensure that the electric field strength is 150mv / mm, and the electrification is continued for 6 hours a day.

[0028] On the 49th day, photographs were taken, scar thickness, hardness and scar elevation index were measured, and scar tissue was stained with HE, Masson and Sudan red. Figure 2 C. In general, the scar group (Con) and the alternating square wave treatment group (SWEFs) had similar degrees of wound re-epithelialization on the 28th day. On the 49th day after injury, the scars in the scar group were bright red, hard, and significantly higher than the skin surface, indicating that the rabbit ear scar model was successfully established. The scars in the SWEFs group were lighter in color, softer, and slightly higher than the skin surface, suggesting that SWEFs can inhibit scar formation.

[0029] See attached Figure 2 D. The scar thickness was measured with a vernier caliper and found that the thickness of normal skin was 3.650±0.1067mm, that of the scar group was 15.30±1.106mm, and that of the alternating electric field group was 9.000±0.6992mm. The hardness was measured with a Rockwell hardness tester and found that the hardness of normal skin was 1.106±0.0909HRC, that of the scar group was 2.990±0.2791HRC, and that of the alternating electric field group was 2.070±0.2578HRC. The scar hyperplasia index (SEI=scar height / normal tissue height) was used to evaluate the scar hyperplasia and found that the SEI of the scar group was 1.591±0.1163HRC, and that of the alternating electric field group was 0.7130±0.1351HRC, indicating that SWEFs can reduce the thickness, hardness and scar hyperplasia index of hypertrophic scars, proving again that SWEFs can inhibit scar formation.

[0030] See attached Figure 2 E, HE staining showed that the thickness of the dermis in the HS group increased, collagen deposition was obvious and arranged in disorder. After SWEFs treatment, the thickness of the dermis decreased, collagen deposition decreased and arranged more regularly, reducing scar hyperplasia. Figure 2 F and attached Figure 2D, Masson staining and Sudan red staining further demonstrated that collagen deposition increased in the HS group and the fibers were fine and disordered, while collagen deposition decreased after SWEFs treatment and the collagen was coarse and orderly, further illustrating the inhibitory effect of SWEFs on scar formation.

[0031] The electric field strength of the square wave electric field in this embodiment is between 50mv / mm and 200mv / mm (including 50mv / mm and 200mv / mm), and the electric field period is between 1min and 60min (including 1min and 60min), and the two can be combined arbitrarily, see the attached Figure 4 , is a combination of electric field strength and electric field period that the inventor has experimentally verified: such as electric field strength of 50mv / mm, electric field period of 30min; electric field strength of 100mv / mm, electric field period of 30min; electric field strength of 150mv / mm, electric field period of 30min; electric field strength of 200mv / mm, electric field period of 30min; such as electric field strength of 50mv / mm, electric field period of 10min; electric field strength of 100mv / mm, electric field period of 10min; electric field strength of 150mv / mm, electric field period of 10min; electric field strength of 200mv / mm, electric field period of 10min.

[0032] The inventors analyzed the results of high-throughput sequencing and found that the square wave alternating electric field may inhibit collagen deposition and myofibroblast transformation by negatively regulating the TGF-β pathway by upregulating Smad7 through p38 / MAPK. Figure 5 A. From the heat map of gene expression differences among the control group (con), TGF-β, and TGF-β+SWEFs, it can be seen that the alternating square wave electric field changed the transcription level. Further study of the differential genes between the TGF-β group and the TGF-β+SWEFs group revealed that the TGF-β+SWEFs group upregulated 960 genes and downregulated 796 genes compared with the TGF-β group. GO enrichment analysis found that the square wave electric field significantly affected cell differentiation and the p38 / MAPK pathway was significantly enriched. KEGG enrichment analysis found that the square wave electric field significantly affected the TGF-β signaling pathway. The results are shown in the attached Figure 5 B. Attachment Figure 5 C and attached Figure 5 D. Visual heat map analysis of TGF-β signaling pathway-related genes and collagen-related genes in the three groups of con, TGF-β, and TGF-β+SWEFs revealed that negative regulators of the TGF-β pathway, such as SMAD6, 7, 9, BMP (bone morphogenetic protein) 2, 7, 6, and ID (differentiation inhibitor molecule) 2, 4, 1, were significantly upregulated. The results are shown in the attached Figure 5E. In summary, it is speculated that square wave alternating electric field may inhibit collagen deposition and myofibroblast transformation by upregulating Smad7 and other negatively regulating TGF-β pathways through p38 / MAPK, which further proves that square wave alternating electric field can inhibit scar formation.

[0033] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution, which should be included in the scope of the claims of the present invention.

Claims

1. A technical method for inhibiting scar hyperplasia by using an alternating square wave electric field, characterized in that: The method is as follows: using an alternating square wave electric field to treat scars, wherein the electric field waveform of the alternating square wave electric field is a square wave, the electric field strength is 50mv / mm-200mv / mm, and the electric field period is 1min-60min.

2. The method according to claim 1, characterized in that The electric field waveform of the alternating square wave electric field is a square wave, and the combinations of electric field strength and electric field period include: or the electric field strength is 50mv / mm, and the electric field period is 30min; or the electric field strength is 100mv / mm, and the electric field period is 30min; or the electric field strength is 150mv / mm, and the electric field period is 30min; or the electric field strength is 200mv / mm, and the electric field period is 30min; or the electric field strength is 50mv / mm, and the electric field period is 10min; or the electric field strength is 100mv / mm, and the electric field period is 10min; or the electric field strength is 150mv / mm, and the electric field period is 10min; or the electric field strength is 200mv / mm, and the electric field period is 10min.

3. A product for treating scars prepared by the method according to any one of claims 1 to 2, characterized in that: The product is a therapeutic device that uses square waves to primarily treat or assist in the treatment of scars.

4. The product according to claim 3, characterized in that The therapeutic device is a portable electric field therapeutic device or an alternating current therapeutic device.

5. The product according to claim 4, characterized in that The conductive electrode sheet of the therapeutic device is attached to the scar at a distance of 0.5 cm.

6. The product according to claim 5, characterized in that The power was applied continuously for 6 hours every day, and the electric field strength was 150mv / mm.

7. The product according to any one of claims 3 to 6, characterized in that The product is an in vitro electrification model product. The alternating electric field power supply of the product is applied to a standard silver / silver chloride electrode, and a small chamber electrification model is formed through ST electrolyte, agar salt bridge, and culture medium.